NCT00269789View on ClinicalTrials.gov

A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1998

Study Completion Date

May 31, 1998

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Ritalin

DRUG

OROS Methylphenidate HCl

DRUG

Placebo

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY